Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma (Q34255215)

31 July 2017

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma (English)

1 reference

31 July 2017

1 reference

20

Hervé Avet-Loiseau

0 references

Florence Magrangeas

7

Florence Magrangeas

0 references

Loïc Campion

9

Loïc Campion

0 references

Thierry Soussi

4

Thierry Soussi

1 reference

31 July 2017

Norbert Ifrah

8

0 references

François Guilhot

François Guilhot

11

0 references

Philippe Moreau

18

Philippe Moreau

1 reference

31 July 2017

15

Thierry Facon

1 reference

31 July 2017

17

Jean-Luc Harousseau

1 reference

31 July 2017

19

Stéphane Minvielle

1 reference

31 July 2017

16

Michel Attal

1 reference

31 July 2017

14

Claire Mathiot

1 reference

31 July 2017

13

Gérald Marit

1 reference

31 July 2017

1

Laurence Lodé

1 reference

31 July 2017

2

Marion Eveillard

1 reference

31 July 2017

10

Catherine Traullé

1 reference

31 July 2017

Valérie Trichet

3

1 reference

31 July 2017

Soraya Wuillème

5

1 reference

31 July 2017

Steven Richebourg

6

1 reference

31 July 2017

Denis Caillot

12

1 reference

31 July 2017

15 July 2010

1 reference

31 July 2017

1 reference

31 July 2017

95

1 reference

31 July 2017

11

1 reference

31 July 2017

1973-1976

1 reference

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Clinical significance of TP53 mutation in myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Mutations of the p53 gene in human myeloma cell lines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

p53 and RAS gene mutations in multiple myeloma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966923

P53 mutations in lymphomas: position matters

28 October 2018

1 reference

12 December 2020

Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias

1 reference

12 December 2020

p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation

1 reference

12 December 2020

Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection

1 reference

12 December 2020

p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy

1 reference

12 December 2020

10.3324/HAEMATOL.2010.023697

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference